# PMV Pharmaceuticals, Inc.: Form 8-K, filed Jun 7, 2024

- Company: [PMV Pharmaceuticals, Inc.](/companies/pmvp.md) (CIK 1699382)
- Form: 8-K
- Filed: 2024-06-07
- Accepted by EDGAR: Jun 7, 2024, 12:32 ET
- Period: 2024-06-06
- Accession: 0001193125-24-156745
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1699382/000119312524156745/d850099d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1699382/000119312524156745/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1699382/000119312524156745/d850099d8k.htm

Filed Jun 7, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-156745. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
